This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

QGE031

Novartis AG

Drug Names(s): QGE-031

Description: QGE031 is an anti-immunoglobulin E antibody.

Deal Structure: QGE031 was licensed by Novartis from Tanox, a wholly owned subsidiary of Genentech (part of the Roche Group).

Partners: Roche Holding AG


QGE031 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug